THE SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKAEMIA: A SINGLE CENTRE STUDY
In Acute lymphoblastic Leukemia (ALL) assessment of molecular response to treatment, assessing minimal residual disease (MRD) is a major independent predictor of treatment outcome. Consequently, MRD is implemented in all ALL-treatment protocols to fill up or to redefine stratification of multifacto...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
University of Zakho
2024-04-01
|
| Col·lecció: | Science Journal of University of Zakho |
| Matèries: | |
| Accés en línia: | https://sjuoz.uoz.edu.krd/index.php/sjuoz/article/view/1240 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|